Effects of Vojta Therapy on Functional Mobility and Gait Parameters in Children With Down Syndrome
Key facts
- Where
- Lahore, PakistanSee the site
Could this be for you?
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 2 and 10 years old?
Source: NCT07248267, who can take part
Where in Pakistan
- HashimLahore, PakistanContact: Muhammad Asif Jvaed, MS-PTTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorTrial details
- Who runs it
- Riphah International University
- Trial code
- NCT07248267
- Record updated
- 25 November 2025
- Original description
This randomized clinical trial investigates the effects of Vojta therapy on functional mobility and gait parameters in children with down syndrome. The study involves 28 male and female children aged 2-10 years old, who will be randomly assigned to one of the two groups i.e. control and experimental group. Key performance outcomes -GMFM 88 and gait outcome assessment -will be assessed both before and after the intervention. The research aims to evaluate the effects of vojta therapy on functional mobility and gait parameters in children with down syndrome. This RCT study will examine the potential key parameters of gait I.e. its spacial parameters that are step length, stride length, stride width, In and out toe and BOS and functional mobility Data will be analyzed through SPSS version 27.00.Read full original descriptionShow less
Effects of Vojta Therapy on Functional Mobility and Gait Parameter in Children With Down Syndrome
This randomized clinical trial investigates the effects of Vojta therapy on functional mobility and gait parameters in children with down syndrome. The study involves 28 male and female children aged 2-10 years old, who will be randomly assigned to one of the two groups i.e. control and experimental group. Key performance outcomes -GMFM 88 and gait outcome assessment -will be assessed both before and after the intervention. The research aims to evaluate the effects of vojta therapy on functional mobility and gait parameters in children with down syndrome. This RCT study will examine the potential key parameters of gait I.e. its spacial parameters that are step length, stride length, stride width, In and out toe and BOS and functional mobility Data will be analyzed through SPSS version 27.00.
Inclusion: Age: 2-10 years old; Confirmed diagnosis of Down syndrome by pediatric neurologist; Written informed consent obtained from parents or guardians; Independent standing and walking abilities assessed by GMFM dimension D and E; Functional hearing and vision, and understanding of instructions which were necessary for the measurement procedures; No other physical therapy or interventions within the past three months.
Exclusion: Presence of other significant medical conditions (e.g., severe cardiac issues); History of orthopedic surgery or significant musculoskeletal issues affecting mobility; Any additional neurological disorders that could confound results; Patient with Serious cognitive \& behavior issues that would interfere with group participation; Participation in other clinical trials during the study period.